
|Videos|June 10, 2021
Ushering in the Golden Era of Alzheimer Drug Development?
Author(s)RJ Tesi, MD
What effect will aducanumab have on Alzheimer disease treatment?
Advertisement
RJ Tesi, MD, discusses the recent aducanumab FDA approval and the implications it will have on the treatment of Alzheimer disease.
Dr Tesi is CEO and Chief Medical Officer of
Newsletter
Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
FDA Grants Breakthrough Therapy Designation to Alixorexton for the Treatment of Narcolepsy Type 1
2
Neurosterix Announces Phase 1 Study of NTX-253 for Schizophrenia
3
FDA Accepts Investigational New Drug Application for COMP360 for PTSD
4
Stress in Sports: What It Really Means and How to Discuss With Athletes
5

















